Biomea Fusion (BMEA) EBIT Margin (2024 - 2026)
Powered by 
Analysis
Biomea Fusion (BMEA) EBIT Margin (2024 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Biomea Fusion | 39.97 Mn | -121.76 Mn | - | -4,855.06% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -4,855.06% |
| Jun 30, 2026 | -4,001.88% |
| Mar 31, 2026 | -2,970.70% |
| Dec 31, 2025 | -2,045.20% |
| Sep 30, 2025 | -3,955.32% |
| Jun 30, 2025 | -6,885.44% |
| Mar 31, 2025 | -6,602.67% |
| Dec 31, 2024 | -3,895.60% |
| Sep 30, 2024 | -2,718.77% |
| Jun 30, 2024 | -2,398.15% |
| Mar 31, 2024 | -2,055.01% |
API Access
Biomea Fusion EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=BMEA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "BMEA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=BMEA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();